Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of males. It also provides estradiol transdermal sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause; and lidocaine and prilocaine cream, a generic version of EMLA cream, which is indicated as a topical anaesthetic for use on normal intact skin for local analgesia, and genital mucous membranes for superficial minor surgery and as a pre-treatment for infiltration anaesthesia. The company was incorporated in 1998 and is based in West Melbourne, Australia.
| Market Capitalization | $11.8368 million |
| P/E Ratio | 0 |
| P/E Growth Ratio | 0 |
| Book Value | 0.03 |
| Dividend Per Share | 0 |
| Earnings Per Share | -0.0027 |
| EBITDA | -2,809 |
| Profit Margin | -0.0906 |
| Operating Margin TTM | -0.4022 |
| Return on Assets TTM | -0.1536 |
| Return on Equity TTM | -8.591 |
| Revenue TTM | 8,429 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2001-06-30 | 739 | |||
| 2002-06-30 | 547.445 | 547.445 | 4,383.977 | |
| 2003-06-30 | 746.307 | 746.307 | 6,715.671 | |
| 2004-06-30 | 3,264.806 | 286 | 3,264.806 | 7,943.596 |
| 2005-06-30 | 2,711.09 | 300 | 2,711.09 | 10,810.757 |
| 2006-06-30 | 517 | 295 | 517 | 12,810 |
| 2007-06-30 | 2,897 | 330 | 2,897 | 12,742 |
| 2008-06-30 | 4,496 | 476 | 4,496 | 11,397 |
| 2009-06-30 | 650 | 15 | 650 | 11,224 |
| 2010-06-30 | 54,904 | 1,913 | 52,991 | 5,017 |
| 2011-06-30 | 89,603 | 3,008 | 86,595 | 6,045 |
| 2012-06-30 | 8,797 | 261 | 8,536 | 5,528 |
| 2013-06-30 | 15,549 | 533 | 15,016 | 6,086 |
| 2014-06-30 | 53,368 | 1,827 | 51,541 | 6,936 |
| 2015-06-30 | 24,616 | 859 | 23,757 | 7,703 |
| 2016-06-30 | 28,009 | 988 | 27,021 | 8,705 |
| 2017-06-30 | 23,321 | 136 | 23,185 | 12,755 |
| 2018-06-30 | 2,687 | 50 | 2,687 | 13,668 |
| 2019-06-30 | 631 | 5,123 | 631 | 13,621 |
| 2020-06-30 | 1,253 | 1,253 | 13,330 | |
| 2021-06-30 | 1,337 | 1,337 | 17,588 | |
| 2022-06-30 | 1,719 | 1,719 | 14,685 | |
| 2023-06-30 | 8,429 | 558 | 7,871 | 11,261 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2001-06-30 | 11,590 | 12,019 | 741 | 15,338 | ||
| 2002-06-30 | 17,847.965 | 18,355.576 | 870.46 | 24,689.308 | ||
| 2003-06-30 | 10,830.387 | 12,846.083 | 1,181.162 | 24,789.308 | ||
| 2004-06-30 | 6,563.682 | 9,757.512 | 1,348.607 | 25,765.924 | ||
| 2005-06-30 | 28,068.033 | 31,093.624 | 1,611.833 | 52,882.844 | ||
| 2006-06-30 | 19,739 | 23,234 | 2,651 | 53,340 | ||
| 2007-06-30 | 17,227 | 20,369 | 2,123 | 58,813 | ||
| 2008-06-30 | 34,366 | 41,267 | 3,158 | 83,135 | ||
| 2009-06-30 | 14,736 | 34,950 | 3,727 | 83,211 | ||
| 2010-06-30 | 58,609 | 83,605 | 3,136 | 85,786 | ||
| 2011-06-30 | 33,159 | 58,995 | 13,283 | 95,825 | ||
| 2012-06-30 | 30,017 | 58,499 | 5,396 | 95,825 | ||
| 2013-06-30 | 22,840 | 52,895 | 6,142 | 95,873 | ||
| 2014-06-30 | 25,775 | 53,221 | 11,164 | 95,873 | ||
| 2015-06-30 | 23,068 | 48,495 | 7,870 | 95,873 | ||
| 2016-06-30 | 29,360 | 53,371 | 9,482 | 95,873 | ||
| 2017-06-30 | 33,974 | 47,306 | 3,381 | 0 | 95,873 | |
| 2018-06-30 | 28,470 | 32,490 | 2,519 | 0 | 95,873 | |
| 2019-06-30 | 18,152 | 24,433 | 2,497 | 0 | 95,879 | |
| 2020-06-30 | 9,206 | 17,836 | 4,987 | 167 | 96,137 | |
| 2021-06-30 | 15,270 | 23,327 | 4,856 | 185 | 114,213 | |
| 2022-06-30 | 5,831 | 14,302 | 5,212 | 224 | 114,563 | |
| 2023-06-30 | 6,232 | 13,285 | 4,589 | 192 | 114,884 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2001-06-30 | 11,590.301 | |||||
| 2002-06-30 | -3,144.783 | -2,744.533 | 6,257.664 | 11,590.301 | 17,847.965 | |
| 2003-06-30 | -10.015 | -7,017.578 | 17,847.965 | 10,830.387 | ||
| 2004-06-30 | 2.989 | -3,965.575 | -4,266.705 | 10,830.387 | 6,563.682 | |
| 2005-06-30 | 23.965 | -5,902.16 | 21,504.351 | 6,563.682 | 28,068.033 | |
| 2006-06-30 | -9,940 | -8,226 | -8,329 | 28,068 | 19,739 | |
| 2007-06-30 | -7,860 | -7,698 | -2,512 | 19,739 | 17,227 | |
| 2008-06-30 | -5,026 | -2,713 | 17,139 | 17,227 | 34,366 | |
| 2009-06-30 | -7,716 | -5,781 | -19,630 | 34,366 | 14,736 | |
| 2010-06-30 | 46,554 | 48,119 | 43,873 | 14,736 | 58,609 | |
| 2011-06-30 | 57,148 | 65,104 | -25,450 | 58,609 | 33,159 | 99,047 |
| 2012-06-30 | 7,391 | -2,432 | -3,142 | 33,159 | 30,017 | 629 |
| 2013-06-30 | 6,926 | 6,335 | -7,177 | 30,017 | 22,840 | 13,413 |
| 2014-06-30 | 27,970 | 36,371 | 2,935 | 22,840 | 25,775 | 33,346 |
| 2015-06-30 | 11,130 | 10,519 | -2,707 | 25,775 | 23,068 | 13,322 |
| 2016-06-30 | 12,981 | 16,506 | 6,292 | 23,068 | 29,360 | 9,992 |
| 2017-06-30 | -243 | 5,376 | 4,614 | 29,360 | 33,974 | 0 |
| 2018-06-30 | -14,182 | -5,282 | -5,504 | 33,974 | 28,470 | |
| 2019-06-30 | -8,325 | -9,938 | -10,318 | 28,470 | 18,152 | |
| 2020-06-30 | -9,471 | -8,533 | -8,946 | 18,152 | 9,206 | |
| 2021-06-30 | -12,629 | -11,414 | 6,064 | 9,206 | 15,270 | |
| 2022-06-30 | -9,834 | -9,174 | -9,439 | 15,270 | 5,831 | |
| 2023-06-30 | -764 | 401 | 5,831 | 6,232 |